2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Development of De Novo Anti-HLA Antibodies after Treatment with/without Rituximab, a B Cell−Depleting Treatment

Y. Sawada, H. Ishida, K. Omoto, T. Nozaki, T. Shimizu, M. Inui, K. Tanabe
Development of Hepatic Ischemia and Reperfusion Injury Is Independent of Myeloid Cell-Derived COX-2

S. Duarte, H. Kato, T. Ishikawa, R. Busuttil, H. Herschman, A. Coito
Development of Micro Bioscaffold as a Multiplex System To Evaluate Bioactive Molecules That Enhance Cell Function

B. Wang, A. Jakus, A. Wu, Y. Wu, J. Zhang, R. Shah, J. Wertheim
Development of New Onset Hypertension in Living Kidney Donors: Are Multiple Renal Arteries a Risk Factor?

M. Elramah, V. Patil, Y. Becker, B. Astor, D. Foley, V. Vidyasagar, R. Hofmann
Diabetes Significantly Impacts Quality of Life Following Kidney Transplant

C. Musgrave, N. Pilch, H. Meadows, J. McGillicuddy, C. Bratton, K. Chavin, P. Baliga, D. Taber
Dichotomous T-Cell Repopulation after Anti-Thymocyte Globulin Induction Therapy in High Immunological Risk and DCD Renal Transplant Recipients

S. Telfer, S. Ullah, T. Fear, A. Mok, A. Jevnikar, P. Luke, A. Sener
Difference in Inflammatory Response between Clinical Allogeneic and Autologous Islet Transplantation

M. Takita, M. Kanak, F. Kunnathodi, R. Shahbazov, M. Lawrence, N. Onaca, B. Naziruddin, M. Levy
Differences between Live and Deceased-Donor Kidney Transplantation in a Centre Performing Protocol Biopsies

A. Schwarz, I. Scheffner, C. Chatzikyrkou, H. Hermann, W. Gwinner
Different Effects of mTOR Inhibitor VS CN Inhibitor on Human B Cells Proliferations and Activation Markers

G. La Monica, L. Xu, G. Chalasani, L. Gallon
Different Sensitivities of Blood Group A and B Antigen-Responsive B Cells to Calcineurin Inhibitors

M. Yamashita, H. Ohdan

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z